Jessica Robin

Jessica Robin

Auto-generated profile, based on publicly available information

Jessica Robin

Winterlight Labs, Toronto, ON, Canada

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Current Biology
Verified
Journal Article
Closed access
IBIva K. Brunec
Iva K. Brunec
BBBuddhika Bellana
Buddhika Bellana
JOJason D. Ozubko
Jason D. Ozubko
VMVincent Man
Vincent Man
JRJessica Robin
Jessica Robin
MMMorris Moscovitch
Morris Moscovitch

1 October 2017 in Current Opinion in Behavioral Sciences
Verified
Journal Article
Closed access
JRJessica Robin
Jessica Robin
MMMorris Moscovitch
Morris Moscovitch

19 October 2020 in Digital Biomarkers
Verified
Journal Article
Open access
PDF file
JRJessica Robin
Jessica Robin
JHJohn E. Harrison
John E. Harrison
LKLiam D. Kaufman
Liam D. Kaufman
FRFrank Rudzicz
Frank Rudzicz
WSWilliam Simpson
William Simpson
MYMaria Yancheva
Maria Yancheva
Speech represents a promising novel biomarker by providing a window into brain health, as shown by its disruption in various neurological and psychiatric diseases. As with many novel digital biomarkers, however, rigorous evaluation is currently lacking and is required for these measures to be used effectively and safely. This paper outlines and provides examples from the literature of evaluation steps for speech-based digital biomarkers, based on the recent V3 framework (Goldsack et al., 2020). The V3 framework describes 3 components of evaluation for digital biomarkers: verification, analytical validation, and clinical validation. Verification includes assessing the quality of speech recordings and comparing the effects of hardware and recording conditions on the integrity of the recordings. Analytical validation includes checking the accuracy and reliability of data processing and computed measures, including understanding test-retest reliability, demographic variability, and comparing measures to reference standards. Clinical validity involves verifying the correspondence of a measure to clinical outcomes which can include diagnosis, disease progression, or response to treatment. For each of these sections, we provide recommendations for the types of evaluation necessary for speech-based biomarkers and review published examples. The examples in this paper focus on speech-based biomarkers, but they can be used as a template for digital biomarker development more generally.

1 November 2020 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
IBIva K. Brunec
Iva K. Brunec
JRJessica Robin
Jessica Robin
RORosanna K. Olsen
Rosanna K. Olsen
MMMorris Moscovitch
Morris Moscovitch
MBMorgan D. Barense
Morgan D. Barense

20 February 2019 in Cerebral Cortex
Verified
Journal Article
Open access
PDF file
EPE Zita Patai
E Zita Patai
AJAmir-Homayoun Javadi
Amir-Homayoun Javadi
JOJason D Ozubko
Jason D Ozubko
AOAndrew O’cAllaghan
Andrew O’cAllaghan
SJShuman Ji
Shuman Ji
HSHugo J Spiers
Hugo J Spiers
Recent research indicates the hippocampus may code the distance to the goal during navigation of newly learned environments. It is unclear however, whether this also pertains to highly familiar environments where extensive systems-level consolidation is thought to have transformed mnemonic representations. Here we recorded fMRI while University College London and Imperial College London students navigated virtual simulations of their own familiar campus (>2 years of exposure) and the other campus learned days before scanning. Posterior hippocampal activity tracked the distance to the goal in the newly learned campus, as well as in familiar environments when the future route contained many turns. By contrast retrosplenial cortex only tracked the distance to the goal in the familiar campus. All of these responses were abolished when participants were guided to their goal by external cues. These results open new avenues of research on navigation and consolidation of spatial information and underscore the notion that the hippocampus continues to play a role in navigation when detailed processing of the environment is needed for navigation.

4 June 2021 in Alzheimer's Research & Therapy
Verified
Journal Article
Open access
PDF file
AYAnthony Yeung
Anthony Yeung
AIAndrea Iaboni
Andrea Iaboni
ERElizabeth Rochon
Elizabeth Rochon
MLMonica Lavoie
Monica Lavoie
CSCalvin Santiago
Calvin Santiago
FMFariya Mostafa
Fariya Mostafa
Background: Language impairment is an important marker of neurodegenerative disorders. Despite this, there is no universal system of terminology used to describe these impairments and large inter-rater variability can exist between clinicians assessing language. The use of natural language processing (NLP) and automated speech analysis (ASA) is emerging as a novel and potentially more objective method to assess language in individuals with mild cognitive impairment (MCI) and Alzheimer’s dementia (AD). No studies have analyzed how variables extracted through NLP and ASA might also be correlated to language impairments identified by a clinician.Methods: Audio recordings (n=30) from participants with AD, MCI, and controls were rated by clinicians for word-finding difficulty, incoherence, perseveration, and errors in speech. Speech recordings were also transcribed, and linguistic and acoustic variables were extracted through NLP and ASA. Correlations between clinician-rated speech characteristics and the variables were compared using Spearman’s correlation. Exploratory factor analysis was applied to find common factors between variables for each speech characteristic.Results: Clinician agreement was high in three of the four speech characteristics: word-finding difficulty (ICC = 0.92, p<0.001), incoherence (ICC = 0.91, p<0.001), and perseveration (ICC = 0.88, p<0.001). Word-finding difficulty and incoherence were useful constructs at distinguishing MCI and AD from controls, while perseveration and speech errors were less relevant. Word-finding difficulty as a construct was explained by three factors, including number and duration of pauses, word duration, and syntactic complexity. Incoherence was explained by two factors, including increased average word duration, use of past tense, and changes in age of acquisition, and more negative valence.Conclusions: Variables extracted through automated acoustic and linguistic analysis of MCI and AD speech were significantly correlated with clinician ratings of speech and language characteristics. Our results suggest that correlating NLP and ASA with clinician observations is an objective and novel approach to measuring speech and language changes in neurodegenerative disorders.